235 related articles for article (PubMed ID: 16829191)
1. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
Medin M; Hermida-Prieto M; Monserrat L; Laredo R; Rodriguez-Rey JC; Fernandez X; Castro-Beiras A
Eur J Heart Fail; 2007 Jan; 9(1):37-43. PubMed ID: 16829191
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.
Fish M; Shaboodien G; Kraus S; Sliwa K; Seidman CE; Burke MA; Crotti L; Schwartz PJ; Mayosi BM
Sci Rep; 2016 Feb; 6():22235. PubMed ID: 26917049
[TBL] [Abstract][Full Text] [Related]
3. [Association between phospholamban gene mutation and dilated cardiomyopathy in the Chengdu area].
Chen XY; Rao L; Zhou B; Zhang L; Chen H; Wang YP; Wang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):683-5. PubMed ID: 16235537
[TBL] [Abstract][Full Text] [Related]
4. Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy.
DeWitt MM; MacLeod HM; Soliven B; McNally EM
J Am Coll Cardiol; 2006 Oct; 48(7):1396-8. PubMed ID: 17010801
[TBL] [Abstract][Full Text] [Related]
5. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy.
Minamisawa S; Sato Y; Tatsuguchi Y; Fujino T; Imamura S; Uetsuka Y; Nakazawa M; Matsuoka R
Biochem Biophys Res Commun; 2003 Apr; 304(1):1-4. PubMed ID: 12705874
[TBL] [Abstract][Full Text] [Related]
7. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.
Haghighi K; Kolokathis F; Gramolini AO; Waggoner JR; Pater L; Lynch RA; Fan GC; Tsiapras D; Parekh RR; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1388-93. PubMed ID: 16432188
[TBL] [Abstract][Full Text] [Related]
9. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a Northern Greek population.
Kalemi T; Efthimiadis G; Zioutas D; Lambropoulos A; Mitakidou A; Giannakoulas G; Vassilikos V; Karvounis H; Kotsis A; Parharidis G; Louridas G
Biochem Genet; 2005 Dec; 43(11-12):637-42. PubMed ID: 16382369
[TBL] [Abstract][Full Text] [Related]
10. A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.
Haghighi K; Chen G; Sato Y; Fan GC; He S; Kolokathis F; Pater L; Paraskevaidis I; Jones WK; Dorn GW; Kremastinos DT; Kranias EG
Hum Mutat; 2008 May; 29(5):640-7. PubMed ID: 18241046
[TBL] [Abstract][Full Text] [Related]
11. PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing.
Landstrom AP; Adekola BA; Bos JM; Ommen SR; Ackerman MJ
Am Heart J; 2011 Jan; 161(1):165-71. PubMed ID: 21167350
[TBL] [Abstract][Full Text] [Related]
12. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
[TBL] [Abstract][Full Text] [Related]
13. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
Li Z; Chen P; Xu J; Yu B; Li X; Wang DW; Wang DW
Int J Cardiol; 2019 Mar; 279():122-125. PubMed ID: 30638982
[TBL] [Abstract][Full Text] [Related]
14. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in patients from southern Poland.
Petkow-Dimitrow P; Kieć-Wilk B; Kwaśniak M; Mikołajczyk M; Dembińska-Kieć A
Kardiol Pol; 2011; 69(2):134-7. PubMed ID: 21332051
[TBL] [Abstract][Full Text] [Related]
15. [Association between mutation of phospholamban gene and dilated cardiomyopathy].
Zhao CX; Cui YH; Zhu ZH; Wang DW
Yi Chuan; 2004 Sep; 26(5):599-602. PubMed ID: 15640069
[TBL] [Abstract][Full Text] [Related]
16. Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.
Young HS; Ceholski DK; Trieber CA
Biochem Cell Biol; 2015 Feb; 93(1):1-7. PubMed ID: 25563649
[TBL] [Abstract][Full Text] [Related]
17. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
[TBL] [Abstract][Full Text] [Related]
18. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.
Haghighi K; Kolokathis F; Pater L; Lynch RA; Asahi M; Gramolini AO; Fan GC; Tsiapras D; Hahn HS; Adamopoulos S; Liggett SB; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
J Clin Invest; 2003 Mar; 111(6):869-76. PubMed ID: 12639993
[TBL] [Abstract][Full Text] [Related]
19. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
Doevendans PA; Glijnis PC; Kranias EG
Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
[TBL] [Abstract][Full Text] [Related]
20. The genetics of dilated cardiomyopathy: a prioritized candidate gene study of LMNA, TNNT2, TCAP, and PLN.
Hirtle-Lewis M; Desbiens K; Ruel I; Rudzicz N; Genest J; Engert JC; Giannetti N
Clin Cardiol; 2013 Oct; 36(10):628-33. PubMed ID: 24037902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
